Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress

被引:29
作者
Meng, Lifei [1 ]
Yang, Xuhui [1 ]
Xie, Xiao [1 ]
Wang, Mingsong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China
关键词
HIF-1; hypoxia; NDUFA4L2; non-small cell lung cancer; ROS; HYPOXIA-INDUCIBLE FACTORS; FACTOR; 1-ALPHA; SURVIVAL; DISEASE; COMPLEX; SITES;
D O I
10.1111/1759-7714.12984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundNon-small cell lung cancer (NSCLC) accounts for a significant proportion of cancer-related deaths and lacks an effective treatment strategy. NSCLC tissues are generally found in a low oxygen environment. The NDUFA4L2 protein, located in the mitochondria, is encoded by the nucleus genome and is considered a crucial mediator that regulates cell survival. A better understanding of the mechanism of NDUFA4L2 in NSCLC survival in hypoxic environments is essential to design new therapeutic methods. MethodsTwenty NSCLC and corresponding paired non-tumorous lung tissue samples were collected. NSCLC cell lines were cultured in hypoxic conditions to investigate the mechanism of NDUFA4L2 in NSCLC. The role of NDUFA4L2 was confirmed by using Western blotting, reactive oxygen species measurement, flow cytometry, immunofluorescence analysis, and wound healing and colony formation assays. ResultsThe expression of HIF-1 and mitochondrial NDUFA4L2 increased in NSCLC cell lines cultured in hypoxic conditions (1% O-2). NDUFA4L2 was drastically overexpressed in human NSCLC tissues and cell lines cultured in hypoxic conditions. HIF-1 regulated the expression of NDUFA4L2. Knockdown of NDUFA4L2 notably increased mitochondrial reactive oxygen species production, which suppressed the viability of NSCLC. ConclusionIn conclusion, overexpression of NDUFA4L2 is a key factor for maintaining NSCLC growth, suggesting that mitochondrial NDUFA4L2 may be a potential target for the treatment of lung cancer.
引用
收藏
页码:676 / 685
页数:10
相关论文
共 34 条
[1]   Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia [J].
Aquino-Galvez, Arnoldo ;
Gonzalez-Avila, Georgina ;
Delgado-Tello, Javier ;
Castillejos-Lopez, Manuel ;
Mendoza-Milla, Criselda ;
Zuniga, Joaquin ;
Checa, Marco ;
Aquiles Maldonado-Martinez, Hector ;
Trinidad-Lopez, Axel ;
Cisneros, Jose ;
Maria Torres-Espindola, Luz ;
Hernandez-Jimenez, Claudia ;
Sommer, Bettina ;
Cabello-Gutierrez, Carlos ;
Gutierrez-Gonzalez, Luis H. .
ONCOLOGY REPORTS, 2016, 35 (01) :577-583
[2]   The Responses of Autophagy and Apoptosis to Oxidative Stress in Nucleus Pulposus Cells: Implications for Disc Degeneration [J].
Chen, Jiang-Wei ;
Ni, Bin-Bin ;
Li, Bo ;
Yang, Yue-Hua ;
Jiang, Sheng-Dan ;
Jiang, Lei-Sheng .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (04) :1175-1189
[3]   Linking measured intercellular oxygen concentration to human cell functions [J].
Ebbesen, P ;
Eckardt, KU ;
Ciampor, F ;
Pettersen, EO .
ACTA ONCOLOGICA, 2004, 43 (06) :598-600
[4]   THE EFFECT OF SURGICAL-TREATMENT ON SURVIVAL FROM EARLY LUNG-CANCER - IMPLICATIONS FOR SCREENING [J].
FLEHINGER, BJ ;
KIMMEL, M ;
MELAMED, MR .
CHEST, 1992, 101 (04) :1013-1018
[5]   Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia [J].
Goda, N ;
Ryan, HE ;
Khadivi, B ;
McNulty, W ;
Rickert, RC ;
Johnson, RS .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (01) :359-369
[6]   Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible factor-1α in non-small cell lung cancer A549 cells [J].
Guo, Qiang ;
Lan, Fei ;
Yan, Xu ;
Xiao, Zhu ;
Wu, Yuelei ;
Zhang, Qin .
ONCOLOGY LETTERS, 2018, 16 (01) :801-808
[7]   Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway [J].
Huang, LE ;
Gu, J ;
Schau, M ;
Bunn, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :7987-7992
[8]   Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation [J].
Jaakkola, P ;
Mole, DR ;
Tian, YM ;
Wilson, MI ;
Gielbert, J ;
Gaskell, SJ ;
von Kriegsheim, A ;
Hebestreit, HF ;
Mukherji, M ;
Schofield, CJ ;
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ .
SCIENCE, 2001, 292 (5516) :468-472
[9]   Diverse somatic mutation patterns and pathway alterations in human cancers [J].
Kan, Zhengyan ;
Jaiswal, Bijay S. ;
Stinson, Jeremy ;
Janakiraman, Vasantharajan ;
Bhatt, Deepali ;
Stern, Howard M. ;
Yue, Peng ;
Haverty, Peter M. ;
Bourgon, Richard ;
Zheng, Jianbiao ;
Moorhead, Martin ;
Chaudhuri, Subhra ;
Tomsho, Lynn P. ;
Peters, Brock A. ;
Pujara, Kanan ;
Cordes, Shaun ;
Davis, David P. ;
Carlton, Victoria E. H. ;
Yuan, Wenlin ;
Li, Li ;
Wang, Weiru ;
Eigenbrot, Charles ;
Kaminker, Joshua S. ;
Eberhard, David A. ;
Waring, Paul ;
Schuster, Stephan C. ;
Modrusan, Zora ;
Zhang, Zemin ;
Stokoe, David ;
de Sauvage, Frederic J. ;
Faham, Malek ;
Seshagiri, Somasekar .
NATURE, 2010, 466 (7308) :869-U103
[10]   Hypoxia-inducible factors, stem cells, and cancer [J].
Keith, Brian ;
Simon, M. Celeste .
CELL, 2007, 129 (03) :465-472